Clinical Trial Update: Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial update for rivaroxaban in neonates with venous or arterial thromboembolism. The study has completed and results were posted in Ju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Thrombosis
• Venous Thromboembolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Thromboembolism | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-07-10